Stocks Higher on Back of Impressive Retail Earnings

Macy's (M) earnings beat is helping retail stocks

by Emma Duncan

Published on May 16, 2018 at 11:58 AM
Updated on May 16, 2018 at 12:04 PM

Despite worries regarding renewed tensions between the U.S. and North Korea, stocks are trading mostly higher at midday. A notable first-quarter beat from Macy's (M) is lifting retail stocks, though Wall Street is keeping an eye on rising bond yields and political uncertainty in Italy. At last check, the Dow Jones Industrial Average (DJI),  S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are cautiously higher. 

Continue reading for more on today's market, including:

  • Hedge funds adjusted their positions on these FANG stocks.
  • Warren Buffett just doubled his stake in this drug stock.  
  • Plus, the retail giant attracting unusual call volume; why Boot Barn stock just soared to another fresh high; and the drug stock plummeting on an FDA rejection.

Midday Market Stats May 16

Department store concern Macy's Inc (NYSE:M) is attracting unusual options volume today, with roughly 58,000 calls traded so far -- about 10 times the intraday norm. Seeing the most action are the May 31.50, 32.50, and 33 calls, and it looks like one trader is rolling May 31.50 calls up and out to the weekly 6/1 32.50-strike calls. M stock was 7.8% higher at $32.28, fresh off a two-year high of $33.03, following the retailer's well-received first-quarter earnings. 

The top performer on the New York Stock Exchange (NYSE) is clothing and shoewear retailer Boot Barn Holdings Inc (NYSE:BOOT), after the company reported an impressive fiscal fourth-quarter earnings beat. BOOT stock is 15.7% higher at $25.40, at last check, just off a more than two-year high of $26.25, pushing its nine-month gain to just under 200%.

Daily Chart of BOOT Since May 2017

The Nasdaq's worst performer today is drug stock Evolus Inc (NASDAQ:EOLS), after the Food and Drug Administration (FDA) rejected the company's Botox rival, citing issues related to chemistry, manufacturing, and the controls process. Evolus stock is down 30.4% at $10.20, easily landing on the short-sale restricted list.

Semiconductor Sell-Off Could be Good News for This Chip Stock
Pullbacks to the 320-day moving average have marked buying opportunities
Time To Bet On a Netflix Stock Rally
The shares are trading near a trendline that has historically bullish implications
Molina Healthcare Stock Could Make a Big Move Higher
A "buy" signal is flashing for MOH again
From Schaeffer's Pro Traders
Weekly Options Secrets Revealed

Direct from our Schaeffer's traders, your FREE guide to winning with weekly options!


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Tax Plan is Never Going to Grow the Economy… Unless This Is Fixed First
Are you ready for a potential economic reset?
Amedisys Carves Out New Highs on Oppenheimer's Latest Hike
AMED nabbed another new record high earlier today
Walmart Earnings, Tesla Share Spotlight With Turkey, Trade
The retailer's earnings have the Dow headed toward a weekly win
The Tax Plan is Never Going to Grow the Economy… Unless This Is Fixed First
Are you ready for a potential economic reset?